The present experiments were undertaken to assess the effect of an atrial extract (ANF) and of the synthetic atriopeptin II (APII) on filtration pressure of rat kidneys. Continuous recordings of stop flow pressure (SFP) were made to obtain an index of the change of glomerular capillary pressure produced by atrial peptides and its time course. Short-term infusion of ANF or APII increased SFP from 40.6 + 0.99 to 50.7 • 1.42 mm Hg (p < 0.001) and from 44.0 ~ 1.28 to 52.7 • 1.75 mm Hg (p < 0.001) respectively. The maximum response was achieved promptly. Return of SFP to control was slow: 20 minutes after termination of the infusion SFP was still elevated by 4.9 • 1.27 mm Hg (p < 0.01). Tubule and stel]ate vessel pressures increased less than 2mm Hg, changes that were not significant. Arterial pressure fell 6 mm Hg (p < 0.05). When arterial pressure was reduced by an aortic clamp to 85-90 mmHg prior to administration of APII the response of SFP was markedly blunted (from a mean increase of 9.0 • 1.07 mm Hg to 4.5 • 0.53 mm Hg). The increase of SFP probably reflects an increase of glomerular capillary pressure.
INTRODUCTION
The effect of the atrial natriuretic peptides on the process of glomerular filtration remains a subject of controversy. A number of early studies suggested that the increase of urinary sodium excretion caused by ANF was not accompanied by a change in glomerular filtration rate (de Bold et al. 1981 , Keeler 1982 , Pollock and Banks 1983 . Sonnenberg et ai.1982 . However, in most recent studies GFR has been found to rise (Beasley and Malvin 1985 , Burnett et ai.1984 . Huang et al. 1985 , Maack et al. 1985 . Seymour et al. 1985 . Measurements of SNGFR of superficial nephrons from our own laboratory demonstrated a dose dependency of filtration rate changes, with significant persistent elevations of filtration rate during infusion of ANF at high doses and smaller increases that did not achieve significance at lower doses (Briggs et al. 1982) .
A similar dose-dependent change of GFR has been observed in another study in rats (Hirata et al, 1985) .
The present experiments were undertaken to study the effect of atrial peptides on filtration pressure using the stop flow pressure (SFP) of single nephrons as. a measure of glomerular capillary pressure. Our results show that atrial peptides induce an immediate and long-lasting increase of SFP. consistent with the notion that hemodynamic alterations are an early consequence of increased plasma levels of ANF. The rats were anesthetized by intraperitoneal injection of 120 mg/kg inactin. Catheters were inserted into the femoral artery for pressure measurement and into the jugular vein. During the surgical preparation the rats received a 4 g% albumin solution in saline in a volume corresponding to 0.5% of body weight at a rate of 1.2 ml/hr followed by a maintenance infusion of 1 g% albumin in saline at 1.2 ml/hr. The left kidney was prepared for micropuncture.
To measure SFP, the pressure measuring pipette (outer diameter 3-5 ~, filled with 1 M NaCI coloured with FD and C Green) was inserted into a random proximal tubule segment. When passage of a small bolus of the coloured solution revealed that the puncture site was early proximal a wax block was injected into a nearby downstream segment. To measure intratubular pressure a servo-null pressure device (WPI, New Haven) was used. When a stable SFP was established atrial extract (ANF) or synthetic atriopeptin 11 (APII) was infused intravenously over a period of 2 minutes. SFP was continuously recorded for periods of up to 30 minutes. The pipette position was controlled and adjusted when necessary. Measurements of proximal tubule free flow and stellate vessel pressures were performed before and within the first 5 min period after ANF infusion. In one series of experiments SFP responses to APII were measured in the same nephron at two different levels of arterial pressure, at normal pressure and after reducing renal arterial pressure to 80-85 mm Hg with a suprarenal aortic clamp.
Urine was collected into tared vessels for 2 periods of 5 min and 2 periods of I0 min after ANF infusion. Na was measured by flame photometry. To prepare ANF, atria from 40 rats (total wet weight 4.0 g) were excised, frozen in liquid nitrogen and pulverized with an electric blender. The powder was dissolved in 40 ml of a I0:I mixture of 0. I N acetic acid in I% NaCI and 1 N HCI and incubated for 60 min at 4~
After 15 min centrifugation at I0.000 rpm the precipitate was resuspended, reincubated and centrifuged. The combined supernatants were pumped through Bondapak CIR (Sep-Pak CI~ ) cartridges in 5 consecutive runs. Aft@~ rinsing wi~ 0.1% di-fluor-acetic acid the cartridges were eluated with 3 ml of 80% acetonitrile in 0.1% di-fluor-acetic acid. The eluate was dried in a vacuum at 30~ resuspended in 16 ml of isotonic saline, divided into 1 ml portions and kept at -20~ until use. The administered volume of 200 ul contained ANF from 1 atrium.
The synthetic peptide used was atriopeptin II (supplied by Dr.
L. Kinter, Smith-Kline-Beckman. Philadelphia. U.S.A.). Statistical significance was determined by the t-test for paired comparisons.
RESULTS
The effect of short-term infusion of ANF or APII on SFP. arterial pressure, volume and Na excretion is An example for the time course of the SFP increase following APII is given in Fig. I . It can be seen that SFP began to rise shortly after start of the infusion and attained maximum values within the first minute after termination of the infusion. Table 2 demonstrates that the effect of atrial peptides on SFP is relatively long-lasting. With ANF SFP increased by a maximum of 9.46 • 1.57 mm Hg. After 20 minutes SFP was still significantly higher than control, by 4.9 • 1.27 mm Hg. SFP changes after APII were higher than control by I0 minutes, but had approached control by 20 minutes. With both ANF and APII urinary Na excretion returned to control faster than SFP.
Mean tubule pressure was 15.2 • 0.37 mm Hg (n=14) in control and 16.6 + 0.84 mm Hg (n=12) in the first 5 minutes after ANF infusion (n.s. Fig.2 . The effect of infusion of atriopeptin II at two levels of arterial pressure Table 3 summarizes the results of studies in which SFP responses to 500 ng APII was measured at two levels of arterial pressure in random sequence. While SFP increased from 45 • 2.07 to 54 • 1.29 mm Hg at normal pressure, it increased only from 36.4 • 1.28 to 41.0 • when AP was reduced to 80-85 mm Hg. An example of such an experiment is shown in Fig. 2 . The mean increase of 9.0 • 1.07 mm Hg at normal pressure was significantly higher than the rise of 4.5 • 0.53 mm Hg during the pressure reduction (p < 0.01). The increase in urine flow and Na excretion was also markedly blunted by the pressure reduction. DISCUSSION The present study demonstrates that an acute elevation of the plasma level of ANF by a brief infusion is followed by a prompt rise of SFP. Experimental comparisons between direct and SFP derived values for glomerular capillary pressure have indicated good agreement between the two methods in most circumstances (Arendshorst and Gottschalk 1985) . But even if the estimate of GCP derived from SFP did deviate somewhat from the true GCP, the observed change in SFP following ANF almost certainly reflects a change in GCP. Any acute effects of nephron obstruction on GCP had presumably reached completion in the 5 period before ANF was given.
Since continuous measurements over prolonged periods could be made, this method had the advantage of permitting the assessment of the transient behavior of filtration pressure during administration and withdrawal of the agent. However, measurements of SFP require the interruption of the tubuloglomerular feedback circuit.
It is therefore possible that in the intact nephron the effect of ANF on GCP would be counter-regulated by increased distal flow. and therefore less pronounced. However ANF apppears to blunt the sensitivity of the tubuloglomerular feedback mechanism (Briggs et al. 1982) , and therefore, interruption of the distal nephron feedback pathway should have relatively little effect on glomerular pressure in this setting.
Since a rise in both GFR (Beasley and Malvin 1985. 1982 , Burnett et al. 1984 , Hirata et al. 1985 , Huang et al. 1985 , Maack et al, 1985 , Seymour et al. 1985 and blood flow (Burnett et al, 1984 , Maack et al 1985 are other acute responses to ANF, it seems likely that the rise of SFP is caused at least in part by preglomerular vasodilatation. Even in the absence of a persistent increase in renal blood flow (Burnett et al. 1984 , Hirata et al. 1985 , intrarenal resistance may be reduced by these compounds since they generally produce a significant reduction of arterial pressure.
Briggs et al,
Recent results suggest that atrial natriuretic peptides do not affect the diameter of isolated afferent or efferent arterioles (Edwards 1985) . Absence of a dilatory effect on glomerular arterioles has also been noted in a hydronephrotic kidney model (Marin-Grez et al, 1985) that permits direct visualization of vessel diameter changes (Steinhausen et al. 1985) .
On the other hand, both interlobular (MarinGrezet al. 1985) and arcuate arteries (Aalkjaer et al. 1985) respond to atrial natriuretic peptides with vasodilatation. Thus, the reduction of preglomerular resistance is probably located predominantly in those larger renal vessels which contribute to intrarenal resistance.
It is possible that postglomerular vasoconstriction may contribute to the rise of stop flow pressure, In the dog it has been shown that during constant infusion of ANF renal blood flow returns to control within a few minutes and may even fall below control values (Burnett et al. 1984 , Maack et al. 1985 . This result together with the consistent finding of an elevation in filtration fraction has been interpreted as evidence for postglomerular vasoconstriction (Beasley and Malvin 1985 , Burnett et al. 1984 , Huang et al, 1985 , Maack et al. 1985 , Seymour et al, 1985 . A similar observation has been made in isolated kidneys that were not pre-constricted (Camargo et al, 1984) . Also, in the studies using the hydronephrotic kidney model (Steinhausen et al. 1983 ) it has been noted that efferent arterioles may respond to ANF with some vasoconstriction (Marin-Grez et al. 1985) .
Our results show that the elevation in SFP produced by atrial peptides is long-lasting, The explanation for this observation is unclear. However, a persistent effect has also been observed in aortic strips which respond to norepinephrine with reduced constriction after transient exposure to atrial peptide (Thompson and Webb, in press). Whatever the explanation for the prolonged elevation in SFP, it is important to note that the hemodynamic alteration outlasts the natriuretic response substantially.
The effect of a given dose of ANF was much less pronounced when arterial pressure was reduced prior to administration of the agent. One may speculate that the reason for the reduced SFP response may be the reduction in baseline resistance caused by the pressure reduction to 85 mm Hg. A clear effect of baseline resistance on the response to ANF has been noted in isolated kidneys (Baines et al. 1983 , Camargo et al. 1984 , A vasodilatery action was only observed when these kidneys were pre-constricted. Some correlation between the natriuresis and the GCP rise following ANF is suggested by the recent observation of Davis et al. (1985) confirmed in the present study that pressure reduction not only blunts the GCP increase, but also severely interferes with the natriuretic response, In summary, native and synthetic ANF produce a prompt and long-lasting increase in stop flow pressure which probably reflects an increase of glomerular capillary pressure, This result provides additional evidence that these compounds have important intrarenal hemodynamic effects. 
